Silverarc Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-500,000	Closed	-$1.42M	–	69
2024 Q1	$1.42M	Buy	+500,000	New	+$1.42M	0.39%	54
2022 Q2	–	Sell	-30,000	Closed	-$386	–	61
2022 Q1	$386	Buy	+30,000	New	+$386	0.16%	54